top of page

The Functionality of Memory T Cells in Preventing AML Relapse in Patients Treated with a Fusion Vaccine 

 

Immunotherapy has shown promise as a treatment approach for patients with hematologic malignancies by engineering one’s immune system to better target a particular antigen. Treatment for hematologic malignancies and relapse prevention has been proposed using a patient’s tumorigenic cells fused to their dendritic cells ex vivo, administered as a vaccine. Anti-PD1 drugs, which block interactions between PD1, a receptor expressed on the surface of T-cells, and PDL1, a ligand expressed on the surface of cancer cells, have been found to enhance the vaccine’s productivity when inoculated simultaneously. Acute Myeloid Leukemia (AML), a potentially fatal cancer of the blood and bone marrow, has a notable history of recurring in previously treated patients. The fusion vaccine has been used as treatment for AML; its success suggests dependency on memory T-cells. Because memory T-cells are programmed to target antigens they have already encountered, memory T-cells exposed to AML and immunotherapy treatment in vitro could serve as a treatment strategy for patients. The functionality of memory T-cells was evaluated by extracting T-cells from AML mice that received no treatment, treatment involving the fusion vaccine, or treatment involving the fusion vaccine and anti-PD1, and injecting those T-cells into AML transgenic mice. Viability and tumor volume were evaluated using infrared imaging every week for five weeks. AML mice that had been treated with T-cells exposed to the fusion vaccine and anti-PD1 had the lowest tumor volumes, confirming the functionality of memory T-cells and demonstrating the efficacy the fusion vaccine and anti-PD1 as a viable cancer therapy.

ABOUT SKYLAR

Screen Shot 2019-11-21 at 7.17.57 PM.png

Skylar Kronrad is a junior at Pine Crest School in Fort Lauderdale, FL. She is interested in cancer research and spent last summer conducting research at Beth Israel Deaconess Medical Center in Boston, MA.

Contact
bottom of page